Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target.

February 22, 2023

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and maintains $37 price target.

Where LivePerson Stands With Analysts

September 13, 9:46 AM

Analysts have provided the following ratings for LivePerson (NASDAQ:LPSN) within the last quarter:

September 12, 1:08 PM

Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:

March 28, 5:09 AM

The stock experienced a surge, raising questions about its valuation and the possibility of it being treated as a meme stock.

January 4, 5:00 PM

During the last three months, 4 analysts shared their evaluations of Janus Henderson Group (NYSE:JHG), revealing diverse outlooks…